Translational Research (2009 - 2010)
Functional Imaging
In prostate cancer, for instance, there is a clear need to develop ways of measuring metastatic spread
to the bone in high risk patients in relatively early stages of the disease as well as better measuring
responses in more advanced disease through, for example, developing and validating skeletal MRI
imaging and by identifying bone and other biomarkers.
Translational research grant
The EORTC GU Group was awarded a grant from EORTC Board for a project studying skeletal MR imaging in patients with prostate cancer (EORTC protocol 30081). This project will study the role of axial skeletal MRI compared to traditional bone scan in evaluating patients with prostate cancer and
assess if this imaging modality can be used for modifying RECIST to determine response to treatment.
This project will possibly be linked to the study in patients failing LHRH therapy.